Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date
symbols : XENE save search
Xenon Pharmaceuticals Announces Closing of $287.5 Million Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Published: 2022-06-27 (Crawled : 19:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: 0.0%
H: 0.51%
C: -4.29%
offering
Xenon Pharmaceuticals Announces Pricing of $250.0 Million Public Offering
Published: 2022-06-23 (Crawled : 03:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: -8.15%
H: 5.85%
C: 3.59%
offering
Xenon Pharmaceuticals Provides Update on Additional Positive Data from the XEN1101 Program
Published: 2022-06-22 (Crawled : 21:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: 7.12%
H: 0.0%
C: 0.0%
xen1101 program positive update
Xenon Pharmaceuticals Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA
Published: 2022-06-21 (Crawled : 12:20) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: 8.06%
H: 0.0%
C: 0.0%
fda meeting positive
Xenon Pharmaceuticals to Present at the 2022 Jefferies Healthcare Conference
Published: 2022-06-01 (Crawled : 22:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: 0.57%
H: 1.81%
C: 0.68%
conference
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2022 Financial Results and Provide Corporate Update
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: -0.22%
H: 0.0%
C: 0.0%
conference results
Xenon Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial to Evaluate XEN1101 as a Treatment for Major Depressive Disorder (MDD)
Published: 2022-05-03 (Crawled : 19:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: -0.22%
H: 0.0%
C: 0.0%
xen1101 treatment for trial
Xenon Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference
Published: 2022-04-04 (Crawled : 22:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: 1.11%
H: 4.55%
C: 4.37%
conference
Xenon Pharmaceuticals Reports 2021 Financial Results and Provides Corporate Update
Published: 2022-03-01 (Crawled : 23:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: -9.48%
H: 16.24%
C: 13.88%
als financial results report results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2021 Financial Results and Provide Corporate Update
Published: 2022-02-22 (Crawled : 22:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: 1.23%
H: 3.1%
C: -10.88%
als financial results conference results
Xenon Pharmaceuticals to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
Published: 2022-02-14 (Crawled : 23:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: 0.72%
H: 1.88%
C: -0.58%
health als thc conference svb leerink global
Expansion Therapeutics Appoints Gary Bridger, Ph.D., to Its Board of Directors
Published: 2022-01-19 (Crawled : 13:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: -0.8%
H: 6.48%
C: 1.93%
expansion therapeutics
Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $15.0 Million Regulatory Milestone
Published: 2022-01-12 (Crawled : 14:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: 3.38%
H: 0.31%
C: -4.18%
NBIX S | $99.19 1.75% -0.48% |
|
Health Technology
|
| O: -0.79%
H: 3.15%
C: 1.82%
milestone bioscience collaboration
Xenon Pharmaceuticals Presents Additional Positive Data from Phase 2b ‘X-TOLE’ Clinical Trial at the Annual Meeting of the American Epilepsy Society (AES 2021)
Published: 2021-12-03 (Crawled : 12:30) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: 1.77%
H: 0.0%
C: 0.0%
phase 2 phase 2b trial positive
Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2021)
Published: 2021-12-03 (Crawled : 12:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: 1.77%
H: 0.0%
C: 0.0%
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
Published: 2021-11-12 (Crawled : 14:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: -7.25%
H: 0.0%
C: 0.0%
conference
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2021 Financial Results and Provide Corporate Update
Published: 2021-11-03 (Crawled : 20:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: -0.26%
H: 6.88%
C: 2.26%
financial results results conference
Xenon Pharmaceuticals Announces Closing of $345 Million Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Published: 2021-10-08 (Crawled : 19:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
| Email alert
Add to watchlist
offering
Xenon Pharmaceuticals Announces Pricing of $300.0 Million Public Offering
Published: 2021-10-06 (Crawled : 02:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: 4.2%
H: 7.62%
C: 2.5%
offering publication
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101
Published: 2021-10-03 (Crawled : 00:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% |
|
Health Technology
|
| O: 69.5%
H: 22.03%
C: 18.82%
phase 2 results topline phase 2b trial conference
USA Holiday (Independence Day) in 2 days
Your saved searches
Save your searches and get alerts when important news are released.
Mentioned Today
APPN | News 4 | $47.15 -0.44% 4.22% |
|
Technology Services
ARQQ | News | $6.2 -1.74% -2.54% |
|
Information
CDNA | News | $22.38 4.19% 0.0% |
|
Health Technology
FNCTF | News | $11.99 |
|
Communications
HLF | News | $21.56 5.43% 0.0% |
|
Distribution Services
HYB | News | $9.16 0% |
|
Miscellaneous
NVAX | News 4 | $57.11 11.04% 0.91% |
|
Health Technology
OKTA | News 4 | $95.96 6.15% -0.61% |
|
Technology Services
OSCR | News | $4.57 7.53% 0.0% |
|
PEGA | News | $49.44 3.34% 0.0% |
|
Technology Services
PM | News 4 | $99.72 0.99% -0.07% |
|
Consumer Non-Durables
TDOC | News | $34.83 4.88% -0.4% |
|
Health Services
TILE | News | $12.695 1.24% 0.0% |
|
Producer Manufacturing
UL | News | $46.29 1.0% -0.02% |
|
Consumer Non-Durables
UNLYF | News | $45.67 |
|
Consumer Non-Durables